In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page

Improvement of EMA’s guidance on post-authorization activities

by In2Pharma | Sep 13, 2017 | News

EMA The best practice guidelines and support documents for marketing authorization holders (MAHs) have been updated by EMA. The amendments involve topics concerning type II variations, post-authorization safety studies (PASS) and changes related to quality aspects....

Recent Posts

  • Update instructions for distribution of DHPC in Luxembourg
  • Diploma for the Responsible Person for Information and Publicity (RIP)
  • Update Procedure for MA applications in Luxembourg
  • Labeling Medicinal products
  • New clarification about Day 0 in local literature search published by EMA

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België